Envista Holdings Co. (NYSE:NVST – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $20.18.
Several equities research analysts have recently weighed in on the company. Piper Sandler increased their price objective on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 3rd. Needham & Company LLC reissued a “hold” rating on shares of Envista in a report on Thursday, March 6th. Morgan Stanley decreased their price target on Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Thursday, March 6th. Mizuho began coverage on Envista in a report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 price target for the company. Finally, Wells Fargo & Company set a $19.00 price target on Envista in a report on Saturday, March 8th.
View Our Latest Research Report on Envista
Institutional Investors Weigh In On Envista
Envista Price Performance
NVST stock opened at $16.63 on Friday. The company has a market capitalization of $2.86 billion, a P/E ratio of -2.56, a PEG ratio of 1.27 and a beta of 1.33. Envista has a twelve month low of $15.15 and a twelve month high of $23.00. The business has a 50 day simple moving average of $19.76 and a 200-day simple moving average of $19.58. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44.
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, equities analysts anticipate that Envista will post 1 EPS for the current year.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More
- Five stocks we like better than Envista
- What does consumer price index measure?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is a Stock Market Index and How Do You Use Them?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Monster Growth Stocks to Buy Now
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.